Title : CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril - Zhu_2016_Eur.J.Clin.Pharmacol_72_681 |
Author(s) : Zhu HJ , Langaee TY , Gong Y , Wang X , Pepine CJ , Cooper-DeHoff RM , Johnson JA , Markowitz JS |
Ref : European Journal of Clinical Pharmacology , 72 :681 , 2016 |
Abstract : Zhu_2016_Eur.J.Clin.Pharmacol_72_681 |
ESTHER : Zhu_2016_Eur.J.Clin.Pharmacol_72_681 |
PubMedSearch : Zhu_2016_Eur.J.Clin.Pharmacol_72_681 |
PubMedID: 26915813 |
Gene_locus related to this paper: human-CES1 |
Gene_locus related to this paper: human-CES1 |
Zhu HJ, Langaee TY, Gong Y, Wang X, Pepine CJ, Cooper-DeHoff RM, Johnson JA, Markowitz JS (2016)
CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril
European Journal of Clinical Pharmacology
72 :681
Zhu HJ, Langaee TY, Gong Y, Wang X, Pepine CJ, Cooper-DeHoff RM, Johnson JA, Markowitz JS (2016)
European Journal of Clinical Pharmacology
72 :681